Determination of MDA as oxidative stress marker and most common type of blood group in asthmatic patients before and after treatment with montelukast drug.
Asthma is a complex chronic inflammatory disorder of airways characterized by airway smooth muscle hypertrophy, hyperplasia and over production of mucous in which many cells and cellular elements play an important role. The aim of the study is to monitor the changes in asthmatic patients before...
Saved in:
| Main Authors: | Jwad Ali Saleh, Shakir Mahmoud Suleiman, Zaidan Jayed Zaidan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tikrit University
2023-02-01
|
| Series: | Tikrit Journal of Pure Science |
| Subjects: | |
| Online Access: | https://tjpsj.org/index.php/tjps/article/view/1164 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of montelukast in asthma treatment in 2025
by: Rafał Pawliczak
Published: (2025-02-01) -
Advancements in stability assessment: a novel method for impurity profiling in Montelukast and Fexofenadine dosage forms by RP-HPLC
by: Vikram S. Gharge, et al.
Published: (2025-07-01) -
Determination of Montelukast Sodium by flow injection chemiluminescence
by: Omar Adnan Hashem, et al.
Published: (2023-01-01) -
COST–EFFECTIVENESS ANALYSIS OF THE MONTELUKAST APPLICATION IN CHILDREN WITH BRONCHIAL ASTHM IN THE CONDITIONS OF THE REPUBLIC OF BELARUS HEALTH CARE SYSTEM
by: I. N. Kozhanova, et al.
Published: (2012-10-01) -
Determination of montelukast and non-sedating antihistamine combination in pharmaceutical dosage forms: A review
by: Abu Reid Imad Osman, et al.
Published: (2025-01-01)